Odyssey Therapeutics, Inc.
ODTX
$20.73
$0.010.05%
NASDAQ
| 06/30/2026 | 03/31/2026 | 06/30/2025 | |||
|---|---|---|---|---|---|
| Net Income | -52.79M | -38.26M | -41.24M | ||
| Total Depreciation and Amortization | 1.04M | 1.17M | 1.27M | ||
| Total Amortization of Deferred Charges | -- | -- | -- | ||
| Total Other Non-Cash Items | 16.06M | 3.25M | 3.29M | ||
| Change in Net Operating Assets | 1.17M | -7.19M | 2.42M | ||
| Cash from Operations | -34.51M | -41.04M | -34.26M | ||
| Capital Expenditure | -186.00K | -148.00K | -29.00K | ||
| Sale of Property, Plant, and Equipment | 281.00K | -- | 84.00K | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | -211.54M | 34.95M | 23.25M | ||
| Cash from Investing | -211.44M | 34.80M | 23.31M | ||
| Total Debt Issued | -- | -- | -- | ||
| Total Debt Repaid | -46.00K | -24.00K | -35.00K | ||
| Issuance of Common Stock | 292.06M | 651.00K | 6.00K | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | -- | -- | 118.75M | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | 143.00K | -143.00K | -- | ||
| Cash from Financing | 292.16M | 484.00K | 118.72M | ||
| Foreign Exchange rate Adjustments | 104.00K | 24.00K | 323.00K | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | 46.31M | -5.73M | 108.09M | ||